1st Quarter - Report

THE KPM GROUP DC LLC for ORPHAZYME US, INC.

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act H.R. 482/S. 350, Newborn Screening Reauthorization Act

LobbyistCovered position, as disclosed
KATHERINE LANDES —
PATROSKI LAWSON —
BENJAMIN MASON —

Contacted: SENATE

Bills named: S. 670 (117th), S. 350 (117th), H.R. 1730 (117th), H.R. 482 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.